BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Leukemia
,
Leukocyte
,
Biofuel
,
Clofibrate
,
rs2300478
,
FXYD4
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
β1/2
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for β1/2
Explore Curated Studies Results
Literature
Most Relevant Literature
Angiopoietin 1 and integrin beta 1b are vital for zebrafish brain development.
Mcm5 Represses Endodermal Migration through Cxcr4a-itgb1b Cascade Instead of Cell Cycle Control.
Combinatorial morphogenetic and mechanical cues to mimic bone development for defect repair.
Alleviation of TGF-β1 induced tubular epithelial-mesenchymal transition via the δ-opioid receptor.
The effects of β1 and β1+2 adrenergic receptor blockade on the exercise-induced mobilization and ex …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Impact of Chronic Treatment by β1-adrenergic Antagonists on Nociceptive-Level (NOL) Index Variation …
Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
Obstructive Sleep Apnea (OSA), Hypertension , β1 Subunit of Maxi-k+ Channel and Cardiovascular Risk
Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administratio…
Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ